bulk price 633-65-8 Berberine HCL

Category:Natural Extracts > Plant Extracts
Product Name:bulk price 633-65-8 Berberine HCL
CAS No.:633-65-8
Standard:ChP, USP, BP, EP, JP, In-house Standards, IP, Ph. Int
Price(USD):Negotiable
Company:Guangzhou Zesheng Tech-Phar Co.,LTD

Basic Info
  • Grade: Food grade, pharmaceutical grade, injection grade

    Factory Location: jiangsu

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Monthly Production Capacity: 10000ton

    Packaging Information: According to customer requirements

  • Delivery Lead Time: 5days

    Sample Provided: yes

    Payment Terms: L/L

    Berberine has shown to be effective in inhibiting cell proliferation and promoting apoptosis in various cancerous cells; MAPK and Wnt/β-catenin pathways affected by Berberine.IC50 value:Target: Anticancer agentThe plant-based alkaloid berberine has potential therapeutic applications for breast cancer, although a better understanding of the genes and cellular pathways regulated by this compound is needed to define the mechanism of its action in cancer treatment. In this review, the molecular targets of berberine in various cancers, particularly breast cancer, are discussed. Berberine was shown to be effective in inhibiting cell proliferation and promoting apoptosis in various cancerous cells. Some signaling pathways affected by berberine, including the MAP (mitogen-activated protein) kinase and Wnt/β-catenin pathways, are critical for reducing cellular migration and sensitivity to various growth factors [1]. Treatment with BBR(Berberine) in rats on the atherogenic diet reduced plasma total cholesterol and nonHDL cholesterol levels by 29%-33% and 31%-41%, respectively, with no significant differences being observed among the three doses [2]. Berberine induced both apoptotic and autophagic death of HepG2 cells, which was associated with a significant activation of AMPK and an increased expression of the inactive form of acetyl-CoA carboxylase (ACC) [3]. Berberine did not show major effects on viability of HEK-293 embryonic kidney and HCT116 colon carcinoma cells and was not toxic in concentrations up to 20 μM. Berberine inhibited β-catenin transcriptional activity and attenuated anchorage-independent growth. As a result of berberine treatment, cellular levels of active β-catenin were reduced concomitant with an increase in the expression of E-cadherin

     

    1. High quality:
    Quality is life. Quality is the most important element of all commodities. We have a laboratory for research in Jiangsu.
    2. Reasonable price:
    We provide high-quality products at competitive prices in China. All customers are welcome to send us inquiries and quotations.
    3. Minimum order quantity:
    Don't worry about the minimum order quantity, our minimum order quantity is 1 gram or less.
    4. Good service.
    fast reaction. We promise to reply within 24 hours including holidays. 5. Fast transportation and safe express delivery.
    We promise to ship the product and provide the tracking number within 3 working days. And we will send it through different courier companies according to the destination country/region.

Send your message to this supplier
  • From:
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service